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A B S T R A C T   
Endosomal escape is considered a crucial barrier that needs to be overcome by integrin-mediated E. coli for gene 
delivery into mammalian cells. Bafilomycin, a potent inhibitor of the H+ proton pump commonly employed to 
lower endosomal pH, was evaluated as part of the E. coli protocol during delivery. We found an increase in green 
fluorescent protein expression up 6.9, 3.2, 5.0, 2.8, and 4.5 fold in HeLa, HEK-293, A549, HT1080, and MCF-7 
respectively, compared to untreated cells. Our result showed for the first time that Inhibition of lysosomal V- 
ATPase enhances E. coli efficiency.   
1. Introduction 
E. coli-based vectors commonly utilize exogenous genes such as 
invasin from Yersinia pseudotuberculosis and listeriolysin O from Listeria 
monocytogene, to enable the transfer of expression plasmids into 
eukaryotic cells [1–3]. However, the transfection efficiency of E. coli 
vectors has generally been low compared to viral vectors due to several 
cellular barriers [4], including cellular uptake of the vector, endosomal 
escape, and nuclear entry. 
Of these, endosomal escape has been one of the major pitfalls that 
limit the endocytosed E. coli vectors from achieving higher gene delivery 
efficiencies [5]. Like other non-viral vector, the inability of the endo-
cytosed E. coli vector to escape the endosome will result in lysosomal 
degradation. Lysosomal degradation is suggested to be as a result of 
decreasing intracellular pH as the vector navigates through the endo-
lysosomal compartment [6]. Therefore, overcoming this lysosomal 
barrier by inhibiting its acidification could potentially enable our vector 
to deliver gene at a much higher rate. To the best of our knowledge, 
inhibition of the lysosomal acidification has not been tested as a method 
to improve the efficiency of gene transfer by the E. coli vector. 
In a previous study, neutralization of the endosome and lysosome 
was achieved by lysosomotropic drug chloroquine that increased the 
efficiency of E. coli delivery by 6-fold in B16F10 cells [7]. This endo-
somal enhancer induced swelling of the endosome and prevented the 
fusion of the endosome to the lysosome without any effect on the 
vacuolar proton-translocating ATPases (V-ATPase). 
The lysosomal V-ATPase is responsible for the continuous production 
of hydrolase that plays a crucial role in the acidification of the endosome 
and degradation of the internalized vector [8–10]. 
Based on these observations, we hypothesized that inhibiting the V- 
ATPase would decrease lysosomal acidification, resulting in a significant 
increase in E. coli gene delivery efficiency. To test this, we pre-incubated 
cells with bafilomycin A1, a macrolide antibiotic that is known to inhibit 
the vacuolar-type H+-ATPases, before invasion with the E. coli vector 
[11–13]. Specifically, HeLa, HT1080, HEK-293, A549 and MCF-7 cells 
were incubated with DMEM containing 1/100 volume of bafilomycin A1 
dissolved in DMSO for 1 h at 37 ◦C in a 5% of CO2 atmosphere. Bafilo-
mycin A1 was prepared by reconstitution in DMSO before it was utilized. 
DMSO was used as a positive control in this experiment. DMSO is 
considered a small amphiphile that enhances cell permeability and 
works as a tool for drug delivery into mammalian cells [14]. 
Next, the cells were invaded with our E. coli vector carrying a pEGFP- 
N2 plasmid that contains a GFP reporter driven by a mammalian CMV 
promoter, using our established invasion protocol [1]. Cells were pre-
sented with E. coli at 1000 multiplicity of infection (MOI) in 6 well plates 
and centrifuged for 10 min at 250×g before incubation for 1 h. This was 
followed by treatment with 80 μg/ml of gentamicin to selectively kill the 
extracellular E. coli for 1 h, after which the plates were incubated for 48 
h with DMEM containing 20 μg/ml of gentamicin. 
To determine the gene delivery efficiency of E. coli vector, 
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